TSCO — Tractor Supply Company

The tape and the news flow both read negative as of 2026-09-13. Q2 2026 (reported July 23, 2026) delivered net sales of $4.54B (+2.3% YoY) against a ~$4.64B consensus, adjusted diluted EPS of $0.81 versus $0.85 expected, and a -1.5% comparable store sales decline; management simultaneously announced a restructuring of Petsense that closes roughly 75 stores (over a third of that chain) and books a $71.7M pre-tax impairment/restructuring charge, and cut the FY2026 outlook. Sell-side followed: DA Davidson, Truist and Piper Sandler trimmed targets, the consensus rating sits at Hold with zero strong buys and one sell, and the 6-month return is -30.12%. The offsetting signals are real but haven't changed the tape: CEO Hal Lawton and director Andre J. Hawaux both bought stock on the open market in early August 2026, BNY Mellon and other institutions have been accumulating, the consensus 12-month target of $37 (recent average $35.89, range $28-$51) implies roughly 12% upside from $33.01, and the 2.645% dividend yield is near a multi-year high.

Revenue growth has decelerated steadily across the last four quarters: +7.2% YoY in the period ended 2025-09-27, +3.3% in 2025-12-27, +3.6% in 2026-03-28, and +2.3% in 2026-06-27 ($4.54B vs $4.44B). Operating margin has compressed YoY in each of those four quarters - 9.22% vs 9.36%, 7.64% vs 8.44%, 6.50% vs 7.19%, and 11.67% vs 13.01% - although the most recent 134bp gap is mostly the one-off $71.7M Petsense charge (~158bp of the quarter's revenue), so underlying Q2 2026 operating margin was roughly flat YoY. Diluted EPS has been flat-to-lower for four straight quarters ($0.49, $0.43, $0.31, $0.69 GAAP / $0.81 adjusted versus $0.45, $0.44, $0.34, $0.81), and the cash-flow line has deteriorated faster than the income statement: TTM operating cash flow fell to $1,286M from $1,828M a year earlier while TTM capex rose to $979M, cutting TTM free cash flow to $307M from $820M. Gross margin is the least clean datapoint in the file (TTM 32.5%; Q2 2026 held at 34.2% vs 34.2% YoY, but Q1 2026 fell to 32.7% from 36.2%), so I would not over-read any single quarter. Net read: this is a real, multi-quarter deceleration with genuine margin and cash-flow pressure rather than a one-quarter blip - but the Q2 comp miss looks partly weather/fuel driven (management says April and June comps were positive and May, during the core spring selling season, was not), so it is best described as a soft patch with a structural pet-category overlay, not a collapse.

Cheap versus its own history, only fair in absolute terms. As of 2026-09-13, TSCO trades at 17.19x TTM EPS of $1.932 versus a five-year average P/E of 24.62x (roughly a 30% discount) and 1.10x TTM sales versus a 1.85x five-year average P/S, with a 2.645% dividend yield well above its recent norm. The forward math is much less flattering: next-FY consensus EPS of $1.934 is essentially flat versus TTM, so the forward P/E is ~17.1x - a market multiple for a company expected to grow revenue only ~1.3% (next-FY estimate $15.95B vs $15.75B TTM) with no EPS growth. PEG of -2.923 is meaningless (negative because trailing growth is negative). The de-rating from 24.6x to 17.2x is not an obvious mispricing: a meaningful part of it is deserved, because the business went from mid-single-digit comps and margin expansion to ~2% revenue growth and margin compression, and free cash flow has fallen while leverage has risen.

At $33.01 on 2026-09-13, the market is pricing roughly 17x for $1.93 of earnings - barely more than the S&P multiple on a company with flat EPS - which means the stock is priced for 'no recovery' rather than for a return to the old growth algorithm. The bull path: the May 2026 weather/fuel drag proves transient, fall/winter categories and the Petsense cleanup normalize margins, VIP Petcare adds higher-margin recurring revenue, and $2.10-$2.20 of EPS in FY2028 at 18-20x is a $38-$44 stock. The bear path: negative comps are structural (pet-category fatigue plus a stretched rural consumer), EPS grinds sideways at $1.85-$1.95, and the multiple settles at 15-16x, which is a $28-$31 stock and lines up almost exactly with the 52-week low ($28.36) and the low-end analyst target ($28). The single swing variable is comparable store sales in the Q3 2026 print (~October 22, 2026); nothing else in the model moves the stock as much.

Weak trend, no bottom confirmed, as of 2026-09-13. RSI(14) was 40.61 - soft, but not oversold, so there is no mean-reversion signal. The $33.01 price sat 5.19% below the 20-day SMA (approximately $34.82), a mere 0.21% above the 50-day SMA (approximately $32.94) and 20.46% below the 200-day SMA (approximately $41.50) - a broken longer-term structure where the only support is a flat 50-day line. Returns were -5.66% over one week, -9.39% over one month, +5.63% over three months and -30.12% over six months, i.e. a sharp intermediate bounce off the low that has now rolled back over. Entry-timing implication: buying mid-range here gets you no edge. Either wait for a reclaim of the 20-day with RSI back above 50 (trend confirmation, likely needs a good Q3 print) or wait for a flush toward the $28-$30 zone near the 52-week low and low-end target. The 200-day at ~$41.50 is the level that would mark a genuine trend repair, and it is far away.

• Sticky inflation on household essentials continues to squeeze the rural consumer's discretionary budget; TSCO's needs-based mix (feed, livestock, pet) holds up, but big-ticket and seasonal categories soften first, which is exactly the pattern in the comps.
• Fuel prices are a direct swing factor for a rural, drive-to-store retailer - management explicitly attributed the Q2 2026 traffic disruption to unusually high fuel prices during the May 2026 spring selling season, so a repeat of that dynamic is a live risk into spring 2027.
• Tariffs and supply-chain input costs: any cost inflation that outruns pricing power lands directly on a 32.5% TTM gross margin that is already thinner than the 5-year norm.
• Industry-wide pet-category demand fatigue is a structural, not seasonal, headwind - it is the reason behind both the Petsense restructuring (75 closures, $71.7M charge) and the VIP Petcare pivot to veterinary services.
• Rate sensitivity: beta of 0.469 and a 2.645% dividend yield make TSCO a relative bond-proxy and rate-sensitive rotation candidate, while D/E of 2.487 and $2.15B of long-term debt (up from $1.76B at 2025-12-27) make refinancing costs and a still-elevated rate backdrop relevant to the cash-flow story.

• Q3 2026 earnings, expected around October 22, 2026 - the single biggest swing factor, with comparable store sales stabilization, Petsense wind-down execution and early VIP Petcare traction all in one print.
• Annualization of the $71.7M Petsense charge and completion of the ~75-store closure program, which should clean up the reported margin and EPS comparisons and clarify the underlying earnings run-rate.
• Fall 'Harvest Fest' and winter/heating prep campaigns as a real-time read on core rural customer engagement heading into the year-end holidays.
• VIP Petcare integration - any evidence that higher-margin, recurring veterinary revenue is attaching to the existing store base would be a genuine multiple-support story rather than a cost-cutting one.
• Continued insider buying and the pace of buybacks at a depressed share price (roughly 524M shares outstanding at a $17.3B market cap), plus first FY2027 guidance that will reveal whether management thinks the reset is over.

• Comps stay negative. If the weather/fuel explanation for the Q2 2026 -1.5% comp is a convenient cover for a structural traffic decline, the entire re-rating thesis fails and the multiple compresses further.
• Free cash flow has genuinely cracked: TTM FCF fell to $307M from $820M a year earlier, TTM operating cash flow fell from $1,828M to $1,286M, TTM capex rose to $979M, and long-term debt rose from $1.764B (2025-12-27) to $2.154B (2026-06-27). The roughly $481M annual dividend is no longer covered by trailing free cash flow.
• Margin compression is multi-quarter, not one-off: Q1 2026 operating margin of 6.50% versus 7.19% a year earlier, TTM gross margin of 32.5%, with elevated promotional intensity and tariff risk on top.
• Balance-sheet cushion is thin for a discretionary retailer: D/E of 2.487, quick ratio of 0.231, and current ratio of 1.334 - fine in normal times, uncomfortable if the rural consumer deteriorates further.
• Execution risk across three simultaneous initiatives (Petsense closures, VIP Petcare integration, elevated remodel/new-store capex) with no margin for a slip, plus a consensus that is already only a Hold with one sell rating and a $28 low target that is just 15% below the 2026-09-13 price.

Tractor Supply is a genuinely high-quality rural franchise (13.1% ROIC, 42.5% ROE, negative accruals of -1.66% meaning cash earnings run ahead of reported net income, 0.47 beta, 2.645% yield) caught in a real soft patch, and at 17.2x versus a 24.6x five-year average it is cheap versus its own history - but it is only fairly valued in absolute terms because consensus EPS of $1.934 for next year is flat and free cash flow has fallen to $307M from $820M while debt has climbed ~$390M year-to-date. This is not a mispriced cyclical trough in the way a semiconductor downturn would be: revenue is still growing 2.3% and ROIC is still 13.1%, so the weakness looks part weather/fuel, part genuine structural stall in the pet category. At $33.01 on 2026-09-13, with RSI at 40.6, price 20.5% below the 200-day, and no confirmation that comps have turned, this is a watchlist name, not a buy - I would want the October 22, 2026 Q3 print to prove the May miss was transient before paying up.

Forward P/E on next-FY EPS: consensus $1.934 multiplied by an 18.6x justified multiple gives ~$36.00, where 18.6x is a ~24% discount to TSCO's five-year average P/E of 24.62x (warranted by the growth reset from mid-single-digit comps to ~2-3% revenue growth and flat EPS) but a premium to low-growth specialty-retail peers on the strength of a 13.1% ROIC, 0.47 beta and 2.645% dividend yield. Cross-checked with ~11.5x forward EV/EBITDA on roughly $1.85B of normalized EBITDA, which lands near $37 and brackets the estimate.